VantaCore Partners has agreed an acquisition financing package consisting of USD100m of equity funding from Trilantic Capital Partners and a USD15m acquisition facility from PNC. PNC has also provided VantaCore with a USD27m senior secured credit facility. "We are excited about this significant new source of acquisition financing and adding

Investment banking advisory firm Evercore Partners has acquired MJC Associates, a commercial real estate advisory boutique. It has also appointed Martin J. Cicco as senior managing director and head of Evercore’s real estate advisory practice. Cicco, who will be based in New York, founded MJC Associates in January 2007. Prior

OFI Private Equity Capital has become the first company to have its environment, social and governance policy rated by EthiFinance, the independent extra-financial research agency, as a listed company made up of the companies held in its portfolio. OFI Private Equity Capital was given the rating AA or 3.5 out

Private equity firm The Riverside Company has acquired Eska Implants as an add-on to its UK-based Summit Medical platform. Based in Lübeck, Germany, Eska manufactures and markets a wide range of implants including hip, knee, shoulder, elbow, spine, hand, foot and modular systems for reconstructive surgeries. The acquisition allows Summit

Biotech company Biocartis has closed a series B equity financing round which raised EUR30m (USD41.3m) from its current shareholder base of life science investors and two new investors from the pharmaceutical/diagnostic industry. The new investors are the Debiopharm Group (Switzerland) and Johnson & Johnson Development Corporation, which have each obtained

Abris Capital Partners, a mid-market CEE-focused private equity group, has signed an agreement to purchase Masterlease Polska, a Polish auto fleet management business. Abris and its syndicate members have partnered with the company’s management to acquire the business from GMAC, the US-based financial services group part-owned by the car manufacturing

Deutsche Bank is launching a private equity fund of funds business within its asset management division following the closing of the Sal Oppenheim Group acquisition. The bank will combine three existing businesses under the new group entitled DB Private Equity: the private equity group of Deutsche Bank Private Wealth Management,

Alimera Sciences, a US-based ophthalmic pharmaceutical company, has set the price band for its proposed initial public offering of six million shares of common stock between USD15 and USD17 per share. The company is seeking to list its common stock on the Nasdaq Global Market under the symbol ALIM. To

Gresham, a UK mid market private equity firm, has completed an investment of GBP12.3m in Lanes Assistance Services. The investment will buy-out existing shareholder Lanes Group plc and provides capital to develop LAS’ infrastructure and personnel to drive future growth. Gresham provided 100 per cent of the funding. With offices